
John S. Brusca
Examiner (ID: 15745)
| Most Active Art Unit | 1631 |
| Art Unit(s) | 1636, 1631, 1805, 1672, 1621 |
| Total Applications | 1495 |
| Issued Applications | 870 |
| Pending Applications | 179 |
| Abandoned Applications | 449 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4083191
[patent_doc_number] => 06162640
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-19
[patent_title] => 'Selection methods'
[patent_app_type] => 1
[patent_app_number] => 8/447515
[patent_app_country] => US
[patent_app_date] => 1995-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 29030
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/162/06162640.pdf
[firstpage_image] =>[orig_patent_app_number] => 447515
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/447515 | Selection methods | May 22, 1995 | Issued |
Array
(
[id] => 3629627
[patent_doc_number] => 05609876
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-11
[patent_title] => 'Peptide vaccines and associated methods for protection against feline leukemia virus'
[patent_app_type] => 1
[patent_app_number] => 8/447925
[patent_app_country] => US
[patent_app_date] => 1995-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12957
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/609/05609876.pdf
[firstpage_image] =>[orig_patent_app_number] => 447925
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/447925 | Peptide vaccines and associated methods for protection against feline leukemia virus | May 22, 1995 | Issued |
| 08/446386 | HUMAN BRAIN PHOSPHODIESTERASE | May 21, 1995 | Abandoned |
Array
(
[id] => 3653337
[patent_doc_number] => 05622705
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-22
[patent_title] => 'Encapsidated recombinant poliovirus nucleic acid and methods of making and using same'
[patent_app_type] => 1
[patent_app_number] => 8/444882
[patent_app_country] => US
[patent_app_date] => 1995-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 36
[patent_no_of_words] => 14211
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/622/05622705.pdf
[firstpage_image] =>[orig_patent_app_number] => 444882
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/444882 | Encapsidated recombinant poliovirus nucleic acid and methods of making and using same | May 18, 1995 | Issued |
Array
(
[id] => 4061956
[patent_doc_number] => 05866403
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'Homologously recombinant slow growing mycobacteria and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 8/444623
[patent_app_country] => US
[patent_app_date] => 1995-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 8271
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866403.pdf
[firstpage_image] =>[orig_patent_app_number] => 444623
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/444623 | Homologously recombinant slow growing mycobacteria and uses therefor | May 18, 1995 | Issued |
Array
(
[id] => 4079800
[patent_doc_number] => 06054288
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-25
[patent_title] => 'In vivo protein production and delivery system for gene therapy'
[patent_app_type] => 1
[patent_app_number] => 8/443936
[patent_app_country] => US
[patent_app_date] => 1995-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 11504
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/054/06054288.pdf
[firstpage_image] =>[orig_patent_app_number] => 443936
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/443936 | In vivo protein production and delivery system for gene therapy | May 17, 1995 | Issued |
Array
(
[id] => 3942659
[patent_doc_number] => 05976873
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Nucleic acid sequences controlling lung cell-specific gene expression'
[patent_app_type] => 1
[patent_app_number] => 8/442809
[patent_app_country] => US
[patent_app_date] => 1995-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 8
[patent_no_of_words] => 35512
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/976/05976873.pdf
[firstpage_image] =>[orig_patent_app_number] => 442809
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/442809 | Nucleic acid sequences controlling lung cell-specific gene expression | May 16, 1995 | Issued |
| 08/438975 | PYRIMIDINE TARGETING HAIRPIN TRIPLEX-FORMING OLIGONUCLEOTIDES | May 10, 1995 | Abandoned |
Array
(
[id] => 3802484
[patent_doc_number] => 05830648
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Assay and method for transcript imaging'
[patent_app_type] => 1
[patent_app_number] => 8/436065
[patent_app_country] => US
[patent_app_date] => 1995-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 8797
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830648.pdf
[firstpage_image] =>[orig_patent_app_number] => 436065
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/436065 | Assay and method for transcript imaging | May 4, 1995 | Issued |
Array
(
[id] => 4011142
[patent_doc_number] => 05879917
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-09
[patent_title] => 'Programmable genotoxic agents and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 8/434664
[patent_app_country] => US
[patent_app_date] => 1995-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 21
[patent_no_of_words] => 24343
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/879/05879917.pdf
[firstpage_image] =>[orig_patent_app_number] => 434664
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/434664 | Programmable genotoxic agents and uses therefor | May 3, 1995 | Issued |
Array
(
[id] => 3645031
[patent_doc_number] => 05637463
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-10
[patent_title] => 'Method to detect protein-protein interactions'
[patent_app_type] => 1
[patent_app_number] => 8/434730
[patent_app_country] => US
[patent_app_date] => 1995-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 8890
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/637/05637463.pdf
[firstpage_image] =>[orig_patent_app_number] => 434730
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/434730 | Method to detect protein-protein interactions | May 3, 1995 | Issued |
Array
(
[id] => 3925282
[patent_doc_number] => 05877010
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-02
[patent_title] => 'Thymidine kinase mutants'
[patent_app_type] => 1
[patent_app_number] => 8/432871
[patent_app_country] => US
[patent_app_date] => 1995-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 28
[patent_no_of_words] => 31496
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/877/05877010.pdf
[firstpage_image] =>[orig_patent_app_number] => 432871
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/432871 | Thymidine kinase mutants | May 1, 1995 | Issued |
Array
(
[id] => 3937694
[patent_doc_number] => 05976552
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Virus vaccines'
[patent_app_type] => 1
[patent_app_number] => 8/430971
[patent_app_country] => US
[patent_app_date] => 1995-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9256
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/976/05976552.pdf
[firstpage_image] =>[orig_patent_app_number] => 430971
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/430971 | Virus vaccines | Apr 27, 1995 | Issued |
| 08/427244 | METHODS FOR GENERATING METABOLIC PATHWAYS | Apr 23, 1995 | Abandoned |
| 08/427071 | METHOD OF MEDIATING INHIBITION OF FAS-LIGAND EXPRESSION THROUGH USE OF RETINOID COMPOUNDS | Apr 20, 1995 | Abandoned |
Array
(
[id] => 1433966
[patent_doc_number] => 06341256
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-22
[patent_title] => 'Consensus configurational bias Monte Carlo method and system for pharmacophore structure determination'
[patent_app_type] => B1
[patent_app_number] => 08/418992
[patent_app_country] => US
[patent_app_date] => 1995-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 38917
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/341/06341256.pdf
[firstpage_image] =>[orig_patent_app_number] => 08418992
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/418992 | Consensus configurational bias Monte Carlo method and system for pharmacophore structure determination | Mar 30, 1995 | Issued |
Array
(
[id] => 3631715
[patent_doc_number] => 05610015
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-11
[patent_title] => 'System to detect protein-RNA interactions'
[patent_app_type] => 1
[patent_app_number] => 8/409561
[patent_app_country] => US
[patent_app_date] => 1995-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 8373
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/610/05610015.pdf
[firstpage_image] =>[orig_patent_app_number] => 409561
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/409561 | System to detect protein-RNA interactions | Mar 22, 1995 | Issued |
Array
(
[id] => 4135715
[patent_doc_number] => 06015686
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-18
[patent_title] => 'Eukaryotic layered vector initiation systems'
[patent_app_type] => 1
[patent_app_number] => 8/404796
[patent_app_country] => US
[patent_app_date] => 1995-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 37
[patent_no_of_words] => 92552
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/015/06015686.pdf
[firstpage_image] =>[orig_patent_app_number] => 404796
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/404796 | Eukaryotic layered vector initiation systems | Mar 14, 1995 | Issued |
Array
(
[id] => 3696371
[patent_doc_number] => 05677176
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-14
[patent_title] => 'Animal derived cell with antigenic protein introduced therein'
[patent_app_type] => 1
[patent_app_number] => 8/404372
[patent_app_country] => US
[patent_app_date] => 1995-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10595
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/677/05677176.pdf
[firstpage_image] =>[orig_patent_app_number] => 404372
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/404372 | Animal derived cell with antigenic protein introduced therein | Mar 14, 1995 | Issued |
Array
(
[id] => 3879853
[patent_doc_number] => 05747662
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Methods and compositions for secretion of heterologous polypeptides'
[patent_app_type] => 1
[patent_app_number] => 8/398617
[patent_app_country] => US
[patent_app_date] => 1995-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 7770
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747662.pdf
[firstpage_image] =>[orig_patent_app_number] => 398617
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/398617 | Methods and compositions for secretion of heterologous polypeptides | Feb 28, 1995 | Issued |